Hassan, M. et al. 2025. Effect of Pemafibrate, a Selective Peroxisome Proliferator-activated Receptor ? Modulator (SPPARM?), on the Lipid Profile, Liver Function, and Liver Fibrosis among Patients with Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Translation: The University of Toledo Journal of Medical Sciences. 13, S3 (Jun. 2025). DOI:https://doi.org/10.46570/utjms-2025-1397.